GIL BASHE ON MEDIKA LIFE

Medicine and Hope Are Allies in Care

In our mandate to provide regulated information, and physicians embracing an “ideology of the right to know,” let’s not suffocate people’s hope.

For centuries, scientists have pursued treatments and cures for pressing and frightening illnesses. Throughout that time, we have called upon shamans and mystics, spiritual healers, pharmacists, physicians and scientists to conjure herbs, vitamins and supplements — chemicals and biologics.

Relying on intellect and knowledge, we embrace science and molecules that can be patented, tested, peer-reviewed and approved by third-party sources. However, as I look at the narratives of those who live and those that die — the people we seek to help and heal — I see within health information and innovation and the provider approach chinks in our armor. I see the too often-untapped human element that transforms marvelous medicines into people’s survival miracles. I see something missing from within the drug research, discovery and review process. I see that medical records remain challenging for professionals and patients to access and apply. I see how thoughtful communication can be used to create hope and avoid hype.

Communication defines how innovation can bring hope to humanity. Hope remains one of the most under-appreciated elements in the patient-treatment process.

I was a team lead when Hoffmann-La Roche introduced the first biologics for the treatment of cancer — alpha interferon. The launch activities included a New York City media briefing. The speaker line-up included the best and the brightest researchers in the biopharma oncology field — including Dr. Jerry Groopman, the now Dina and Raphael Recanati Chair of Medicine at Harvard Medical School, Chief of Experimental Medicine at Beth Israel Deaconess Medical Center. Groopman is an outstanding scientist who has grappled for years with the role “hope” plays in healing.

Through the years, I have revisited Groopman’s outstanding volume, The Anatomy of Hope — How People Prevail in the Face of Illness. The book recounts his journey into medicine. The challenges physicians face as they look into the stares of people they treat with a life-threatening illness and chronic disease. The physician’s hunger for information and how the “ideology of the right to know,” can also suffocate patient hope. It’s the story of a great physician/scientist trying to balance his passion for the lab and patient care, with the universe we cannot see or touch.

“I understand hope as an emotion made up of two parts: a cognitive part and an effective part. When we hope for something, we employ, to some degree, our cognition, marshaling information and data relevant to a desired future event. If…you are suffering with a serious illness and you hope for improvement, even for a cure, you have to generate a different vision of your condition in your mind. That picture is painted in part by assimilating information about the disease and its potential treatments.

“But hope also involves what I would call affective forecasting — that is, the comforting, energizing, elevating feeling that you experience when you project in your mind a positive future. This requires the brain to generate a different affective, or feeling, state than the one you are currently in.”

Jerome Groopman, The Anatomy of Hope — How People Prevail in the Face of Illness

Throughout my career journey, as a combat medic, health policymaker, health communications professional, I embraced (and will continue to respect) orders and legal, medical and regulatory direction. Along with my rewarding life in heath communications, as an ordained rabbi, called upon to visit the ill and very ill, I find myself walking hospital hallways and being welcomed into people’s homes, listening, comforting and, yes, hoping for their recovery and return to health.

In the past 30 years, I have been privileged to help biopharmaceutical and health tech companies introduce scores of new medicines and devices into the marketplace for lifestyle and medical conditions. Today, in my varied leadership roles, I see my colleagues around the world dedicate themselves — with incredible heart and smarts — to ensure balanced, accurate information is shared so that people — patients, physicians, payers and advocates — can make informed decisions on next steps.

I remain amazed at how many obstacles exist that diminish quality care and people’s — both physician’s and patient’s hope — from challenges to accessing medical records as people journey from one medical institution to another to switching people’s medication for no apparent reason to struggling to gain sufficient talk time with their doctor to understand what is happening with their medical condition.

It’s frustrating. Yet, let us not despair. Let’s be optimistic. Medicine and hope are allies in healing. Communication is not separate from the collective mission to heal. Communication is hope’s bridge that unites science with care, and physicians and patients with their inner fire to heal and be healed.

PATIENT ADVISORY

Medika Life has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by Medika Life

Gil Bashehttps://gil-bashe.medium.com/
Health advocate connecting the dots to transform biopharma, digital health and healthcare innovation | Managing Partner, Chair Global Health FINN Partners | MM&M Top 50 Health Influencer | Top 10 Innovation Catalyst. Gil is Medika Life editor-in-chief and an author for the platform’s EcoHealth and Health Opinion and Policy sections. Gil also hosts the HealthcareNOW Radio show Healthunabashed, writes for Health Tech World, and is a member of the BeingWell team on Medium.

GIL BASHE

Editor in Chief, Medika Life

Meet the Medika.Life new editor-in-chief, working closely with founding editors Robert Turner and Jeff Livingston, MD.

Not your usual health-industry executive, Gil Bashe has had a unique career shaped by more than three decades in healthcare policy, pharma, life science, digital health and venture capital and informed his determination to ‘give back.’

A champion for health innovation that sustains people’s lives and improves their care, Gil honed his perspectives on both battlefield and boardroom. He started in health as a combat medic in an elite military unit. He went on to serve as a clergyman tending to the ill; as a health products industry lobbyist; as CEO of one of the world’s largest integrated health marketing companies; as a principal in private equity; as a Medika Life author and Health Tech World correspondent; and as Chair, Global Health at FINN Partners, a community of purpose dedicated to making a difference.

In the forefront of change, Gil is ranked as a Top 10 Digital Health Influencer; Medical Marketing & Media Top 10 Innovation Catalyst; Medika Life named him a “Top 50 Global Healthcare Influencer,” and PM360 presented him with its “Trailblazer Lifetime Achievement Award.” He is a board member for digital health companies and serves as advisor to the CNS Summit, Galien Foundation, Let’s Win for Pancreatic Cancer, Marfan Foundation and other health-centered organizations.

CONNECT WITH GIL

ON TWITTER

ON LINKEDIN

ON MEDIUM

All articles, information and publications featured by the author on thees pages remain the property of the author. Creative Commons does not apply and should you wish to syndicate, copy or reproduce, in part or in full, any of the content from this author, please contact Medika directly.